Ticagrelor Increases SIRT1 and HES1 mRNA Levels in Peripheral Blood Cells from Patients with Stable Coronary Artery Disease and Chronic Obstructive Pulmonary Disease

Ticagrelor is a powerful P2Y(12) inhibitor with pleiotropic effects in the cardiovascular system. Consistently, we have reported that in patients with stable coronary artery disease (CAD) and concomitant chronic obstructive pulmonary disease (COPD) who underwent percutaneous coronary intervention (P...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Int J Mol Sci
Autors principals: Aquila, Giorgio, Vieceli Dalla Sega, Francesco, Marracino, Luisa, Pavasini, Rita, Cardelli, Laura Sofia, Piredda, Anna, Scoccia, Alessandra, Martino, Valeria, Fortini, Francesca, Bononi, Ilaria, Martini, Fernanda, Manfrini, Marco, Pannuti, Antonio, Ferrari, Roberto, Rizzo, Paola, Campo, Gianluca
Format: Artigo
Idioma:Inglês
Publicat: MDPI 2020
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7084534/
https://ncbi.nlm.nih.gov/pubmed/32106619
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms21051576
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars